Reinfection of mice with respiratory syncytial virus
- PMID: 1885946
- DOI: 10.1002/jmv.1890340103
Reinfection of mice with respiratory syncytial virus
Erratum in
- J Med Virol 1991 Dec;35(4):307
Abstract
A BALB/c model of respiratory syncytial virus infection has been developed in which high-titered replication occurs in lung, immunological infiltrates in lung can be detected histologically, and illness can be consistently reproduced. The immunodeterminants of RSV reinfection in this system were investigated by rechallenging mice with RSV early (less than 2 months after primary infection) and late (16 to 21 months after primary infection) and correlating illness and titer of RSV isolated from lungs and noses with RSV-specific serological responses and lung histology. After early rechallenge, RSV was cleared within 24 hours from both nose and lung. After late rechallenge, RSV was isolated at 72 hours from nose in 21/24 mice, but from lung in only 5/24 mice. Isolation of RSV from lung after rechallenge was associated with low RSV-specific antibody titers measured by ELISA and plaque-reduction neutralization. The presence of lymphocyte aggregates around the bronchovascular bundles was associated with inability to isolate RSV from lung and lack of illness. The basophilic lymphocytes were small and uniform in size with dense nuclei and a small amount of cytoplasm. These studies demonstrate that nasal and pulmonary reinfection with RSV is possible in mice after late rechallenge. The studies also indicate the potential importance of RSV-specific antibody in protecting lung from reinfection.
Similar articles
-
Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.J Clin Invest. 1991 Sep;88(3):1026-33. doi: 10.1172/JCI115362. J Clin Invest. 1991. PMID: 1909350 Free PMC article.
-
Primary respiratory syncytial virus infection in mice.J Med Virol. 1988 Oct;26(2):153-62. doi: 10.1002/jmv.1890260207. J Med Virol. 1988. PMID: 3183639
-
Respiratory syncytial virus infection in anti-mu-treated mice.J Virol. 1991 Sep;65(9):4936-42. doi: 10.1128/JVI.65.9.4936-4942.1991. J Virol. 1991. PMID: 1908028 Free PMC article.
-
Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum.Pediatr Res. 1993 Aug;34(2):167-72. doi: 10.1203/00006450-199308000-00013. Pediatr Res. 1993. PMID: 8233720
-
Topical immunoprophylaxis of respiratory syncytial virus (RSV)-challenged mice with RSV-specific immune globulin.J Infect Dis. 1995 Jun;171(6):1468-74. doi: 10.1093/infdis/171.6.1468. J Infect Dis. 1995. PMID: 7769280
Cited by
-
Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.Virus Res. 2011 Dec;162(1-2):80-99. doi: 10.1016/j.virusres.2011.09.020. Epub 2011 Sep 22. Virus Res. 2011. PMID: 21963675 Free PMC article. Review.
-
Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model.Vaccine. 2007 Aug 14;25(33):6211-23. doi: 10.1016/j.vaccine.2007.05.068. Epub 2007 Jun 26. Vaccine. 2007. PMID: 17629376 Free PMC article.
-
Programmed death-1 impairs secondary effector lung CD8⁺ T cells during respiratory virus reinfection.J Immunol. 2014 Nov 15;193(10):5108-17. doi: 10.4049/jimmunol.1302208. Epub 2014 Oct 22. J Immunol. 2014. PMID: 25339663 Free PMC article.
-
Animal pneumoviruses: molecular genetics and pathogenesis.Clin Microbiol Rev. 2004 Apr;17(2):390-412. doi: 10.1128/CMR.17.2.390-412.2004. Clin Microbiol Rev. 2004. PMID: 15084507 Free PMC article. Review.
-
Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment.Clin Microbiol Rev. 1999 Apr;12(2):298-309. doi: 10.1128/CMR.12.2.298. Clin Microbiol Rev. 1999. PMID: 10194461 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources